HuGE Literature Finder
Records
1
-
3
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. Scientific reports 2020 Aug 10 (1): 13359. Jeong Seri, Park Yu Jin, Yun Woobin, Lee Seung-Tae, Choi Jong Rak, Suh Cheolwon, Jo Jae-Cheol, Cha Hee Jeong, Jeong Jee-Yeong, Chang HeeKyung, Cha Yoon Jin, Kim Hyerim, Park Min-Jeong, Song Wonkeun, Cho Eun-Hae, Jeong Eun-Goo, Lee Junnam, Park Yongmin, Lee Yong Seok, Kim Da Jung, Lee Ho S |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. British journal of haematology 2019 Aug . Lockmer Sandra, Ren Weicheng, Brodtkorb Marianne, Østenstad Bjørn, Wahlin Björn E, Pan-Hammarström Qiang, Kimby E |
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. The Lancet. Oncology 2015 Sep 16 (9): 1111-22. Pastore Alessandro, Jurinovic Vindi, Kridel Robert, Hoster Eva, Staiger Annette M, Szczepanowski Monika, Pott Christiane, Kopp Nadja, Murakami Mark, Horn Heike, Leich Ellen, Moccia Alden A, Mottok Anja, Sunkavalli Ashwini, Van Hummelen Paul, Ducar Matthew, Ennishi Daisuke, Shulha Hennady P, Hother Christoffer, Connors Joseph M, Sehn Laurie H, Dreyling Martin, Neuberg Donna, Möller Peter, Feller Alfred C, Hansmann Martin L, Stein Harald, Rosenwald Andreas, Ott German, Klapper Wolfram, Unterhalt Michael, Hiddemann Wolfgang, Gascoyne Randy D, Weinstock David M, Weigert Oliv |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: